The γ-secretase complex:: Membrane-embedded proteolytic ensemble

被引:157
作者
Wolfe, Michael S. [1 ]
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
D O I
10.1021/bi060799c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
gamma-Secretase is responsible for the proteolytic processing of a variety of membrane-associated fragments derived from type I integral membrane proteins, including the amyloid beta-protein precursor and the Notch receptor. This enzyme is composed of four different integral membrane proteins: presenilin, nicastrin, Aph-1, and Pen-2. During assembly and maturation of the protease complex, presenilin is endoproteolyzed into two subunits, each of which contributes one aspartate to the active site of an aspartyl protease. Substrate apparently interacts with an initial docking site before passing in whole or in part between the two presenilin subunits to the internal water-containing active site. The ectodomain of nicastrin also interacts with the N-terminus of the substrate as an essential step in substrate recognition and processing. Sites for allosteric regulation on the protease complex allow selective inhibition or modulation of APP processing without interfering with Notch signaling, and such selective agents may represent promising leads for the development of Alzheimer's disease therapeutics. Elucidation of detailed structural features of gamma-secretase and other membrane-embedded proteases is the next frontier in understanding how these enzymes carry out hydrolysis within the lipid bilayer.
引用
收藏
页码:7931 / 7939
页数:9
相关论文
共 104 条
[1]
Interaction with telencephalin and the amyloid precursor protein predicts a ring structure for presenilins [J].
Annaert, WG ;
Esselens, C ;
Baert, V ;
Boeve, C ;
Snellings, G ;
Cupers, P ;
Craessaerts, K ;
De Strooper, B .
NEURON, 2001, 32 (04) :579-589
[2]
The levels of, mature glycosylated nicastrin are regulated and correlate with γ-secretase processing of amyloid β-precursor protein [J].
Arawaka, S ;
Hasegawa, H ;
Tandon, A ;
Janus, C ;
Chen, FS ;
Yu, G ;
Kikuchi, K ;
Koyama, S ;
Kato, T ;
Fraser, PE ;
St George-Hyslop, P .
JOURNAL OF NEUROCHEMISTRY, 2002, 83 (05) :1065-1071
[3]
Notch signaling: Cell fate control and signal integration in development [J].
Artavanis-Tsakonas, S ;
Rand, MD ;
Lake, RJ .
SCIENCE, 1999, 284 (5415) :770-776
[4]
PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations [J].
Baki, L ;
Shioi, J ;
Wen, P ;
Shao, ZP ;
Schwarzman, A ;
Gama-Sosa, M ;
Neve, R ;
Robakis, NK .
EMBO JOURNAL, 2004, 23 (13) :2586-2596
[5]
Selected non-steroidal anti-inflammatory drugs and their derivatives target γ-secretase at a novel site -: Evidence for an allosteric mechanism [J].
Beher, D ;
Clarke, EE ;
Wrigley, JDJ ;
Martin, ACL ;
Nadin, A ;
Churcher, I ;
Shearman, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (42) :43419-43426
[6]
Presenilin clinical mutations can affect γ-secretase activity by different mechanisms [J].
Bentahir, M ;
Nyabi, O ;
Verhamme, J ;
Tolia, A ;
Horré, K ;
Wiltfang, J ;
Esselmann, H ;
De Strooper, B .
JOURNAL OF NEUROCHEMISTRY, 2006, 96 (03) :732-742
[7]
Discovery of a subnanomolar helical D-tridecapeptide inhibitor of γ-secretase [J].
Bihel, F ;
Das, C ;
Bowman, MJ ;
Wolfe, MS .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (16) :3931-3933
[8]
Two domains within the first putative transmembrane domain of presenilin 1 differentially influence presenilinase and γ-secretase activity [J].
Brunkan, AL ;
Martinez, M ;
Wang, J ;
Walker, ES ;
Beher, D ;
Shearman, MS ;
Goate, AM .
JOURNAL OF NEUROCHEMISTRY, 2005, 94 (05) :1315-1328
[9]
RELEASE OF EXCESS AMYLOID BETA-PROTEIN FROM A MUTANT AMYLOID BETA-PROTEIN PRECURSOR [J].
CAI, XD ;
GOLDE, TE ;
YOUNKIN, SG .
SCIENCE, 1993, 259 (5094) :514-516
[10]
Nicastrin interacts with γ-secretase complex components via the N-terminal part of its transmembrane domain [J].
Capell, A ;
Kaether, C ;
Edbauer, D ;
Shirotani, K ;
Merkl, S ;
Steiner, H ;
Haass, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) :52519-52523